Roche

Another safety scare for Roche

Another safety scare for Roche

By Anna Lewcock

In another safety concern over a long-approved drug, Roche has been
forced to add new warnings to its anti-transplant rejection drug
CellCept (mycophenolate mofetil (MMF)) amid the news that it is
associated with increased risk of...

Kiddy Tamiflu for the EU

Kiddy Tamiflu for the EU

By Anna Lewcock

Roche has just had the child-size, lower strength version of its
blockbuster flu treatment Tamiflu (oseltamivir) approved by EU
authorities, though possibly just a little too late for this year's
flu season.

Viracept continues to spiral

Viracept continues to spiral

By Anna Lewcock

The latest act in the Viracept (nelfinavir) debacle has seen Roche
officially lose marketing authorisation for the HIV treatment,
following reports of high levels of genotoxic contamination in the
drug.

Viracept saga continues

Viracept saga continues

By Anna Lewcock

In the latest episode of the Viracept contamination case, the drug
is now at risk of losing its marketing authorisation across Europe
while the dangers posed by the chemical contaminant are established
and manufacturer Roche rectifies...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers